Lasa Supergenerics Ltd Share Price

Pharmaceuticals - Indian - Bulk Drugs & Formln M/SNSE
₹5.32
-0.28-5.00% (1D)
As on 5 Oct 2026 at 23:16
As of 5 Oct 2026 at 23:16, Lasa Supergenerics Ltd is trading at ₹5.32, with a market cap of ₹27.00 crore. At a P/E of 0.00 and a dividend yield of 0.00%, it is a small-cap stock in the Pharmaceuticals sector.

LASA Price Chart

Market Cap
₹27.00 Cr
PE Ratio
0.00
ROCE
-22.21%

Lasa Supergenerics Ltd Performance

Lasa Supergenerics Ltd Fundamentals

Market Cap₹27.00 Cr
ROE-26.30%
P/E Ratio (TTM)0.00
EPS (TTM)₹0.00
P/B Ratio0.54
Dividend Yield0.00%
Industry P/E88.19
Book Value₹9.90
Debt to Equity0.20
Face Value₹10

Lasa Supergenerics Ltd Shareholding Pattern

Promoter53.6%
Foreign Institutions0%
Mutual Funds0%
Domestic Institutions0%
Public46.4%

Lasa Supergenerics Ltd Financial Statements

04080120160₹104FY24+36.52%₹142FY25-82.35%₹25FY26

*All values are in INR Crore

Lasa Supergenerics Ltd Peer Comparison

StocksLTP(₹)Market Cap(Cr)52 Week Low-High(₹)
Sun Pharmaceutical Industries Ltd
₹1,782.00
-19.00(-1.05%)
4,27,561.51,583.7 - 2,046.9
Torrent Pharmaceuticals Ltd
₹4,755.15
-12.15(-0.25%)
1,80,870.6—
Cipla Ltd
₹1,334.00
-10.00(-0.74%)
1,07,769.9—
Dr Reddys Laboratories Ltd
₹1,208.00
1.80(+0.15%)
1,00,829.4—
Lupin Ltd
₹2,010.00
-21.20(-1.04%)
91,915.3—

About Lasa Supergenerics

Lasa Supergenerics Limited was incorporated on March 11, 2016. The Company is primarily engaged in the business of manufacturing, trading, producing, processing, preparing, treating chemicals, API, Pharmaceuticals, drugs, etc. The Company is a vertically integrated group spanning the entire veterinary, animal and human healthcare value chain-from discovery-to-delivery, with established credentials in research, manufacturing and global marketing. The Company is a veterinary API manufacturing entity, which was acquired in April, 2012. The manufacturing facility is located at Mahad & Chiplun, in the Konkan region of Maharashtra. It specialises in catalyst chemistry' and manufactures anthelmintic / veterinary API products with largest production capabilities and product categories in India. To efficiently control the supply chain, the Company is fully backward integrated for its key molecules-from discovery research up to full-scale bulk production. The Company's marketing footprint is entrenched across developing markets in multiple countries. Similarly, the group expects to augment its export footprint significantly in width and depth in the future. The Company launched two new block buster products with all-time strong segment, Oxycozanide. Oxyclozanide is an anthelmintic, used in the treatment and control of fascioliasis a topical worm infection in ruminants mainly domestic animals such as cattle, especially buffalos in farm, sheep, and goats. For this, the Company is setting up capacity in a brown field expansion at its Chiplun unit with a total capacity of 20 MT. It got huge demand all over the globe as it is manufactured and have strong entry barriers. The Scheme of Amalgamation of Harishree Aromatics and Chemicals Private Limited with the Company and their respective shareholders was approved by Hon'ble National Company Law Tribunal on December 23, 2022 which became effective from January 04, 2023 in year 2022-23. Following the said Scheme of Amalgamation, 1000 Equity Shares of Rs 10/- per share of the Company was allotted for every 35 Equity Shares of Rs 10/- of Harishree Aromatics and Chemicals Private Limited on January 5, 2023.

Parent Organisation—
Founded2016
Managing Director—
NSE SymbolLASA

Lasa Supergenerics Ltd Resistance and Support levels

R35.60R25.60R15.60S15.60S25.60S35.605.32

Lasa Supergenerics Ltd Technicals

Current Price
₹5.32 ₹0.28 (-5.00%)
Bearish
12
Bullish
0
  • 20 Day20.1%
  • 50 Day24.2%
  • 100 Day27.9%
  • 200 Day38.4%

Lasa Supergenerics Ltd Latest News

View More
26 AUG 2026 | Wednesday
LASA Supergenerics appoints Janardan Kamlu Savala as Executive Director, pending shareholder approval
20 MAY 2026 | Wednesday
Lasa Supergenerics to convene board meeting

2026

Board MeetingAnnounced
Quarterly ResultRelease dateCheck Latest financial
Quarterly ResultRelease dateCheck Latest financial
Quarterly ResultRelease dateCheck Latest financial
Board MeetingAnnounced

Frequently asked questions

The share price of Lasa Supergenerics Ltd is ₹5.32 as of 5 Oct 2026 at 23:16.

Not sure where to start?

Book a free 30-minute consultation with our investment experts today!

Invest Now